Skip to main content
PMC home page
Gut logoLink to Gut
. 1991 Sep;32(Suppl):S86–S91. doi: 10.1136/gut.32.suppl.s86

Acute liver failure.

R D Hughes 1, J Wendon 1, A E Gimson 1
PMCID: PMC1405220  PMID: 1916476

Full text

PDF
S90

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alam A. N., Poston L., Wilkinson S. P., Golindano C. G., Williams R. A study in vitro of the sodium pump in fulminant hepatic failure. Clin Sci Mol Med. 1978 Oct;55(4):355–363. doi: 10.1042/cs0550355. [DOI] [PubMed] [Google Scholar]
  2. Bihari D., Gimson A. E., Lindridge J., Williams R. Lactic acidosis in fulminant hepatic failure. Some aspects of pathogenesis and prognosis. J Hepatol. 1985;1(4):405–416. doi: 10.1016/s0168-8278(85)80778-9. [DOI] [PubMed] [Google Scholar]
  3. Bihari D., Gimson A. E., Waterson M., Williams R. Tissue hypoxia during fulminant hepatic failure. Crit Care Med. 1985 Dec;13(12):1034–1039. doi: 10.1097/00003246-198512000-00010. [DOI] [PubMed] [Google Scholar]
  4. Bihari D., Hughes R. D., Gimson A. E., Langley P. G., Ede R. J., Eder G., Williams R. Effects of serial resin hemoperfusion in fulminant hepatic failure. Int J Artif Organs. 1983 Nov;6(6):299–302. [PubMed] [Google Scholar]
  5. Canalese J., Gimson A. E., Davis C., Mellon P. J., Davis M., Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut. 1982 Jul;23(7):625–629. doi: 10.1136/gut.23.7.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Canalese J., Gove C. D., Gimson A. E., Wilkinson S. P., Wardle E. N., Williams R. Reticuloendothelial system and hepatocytic function in fulminant hepatic failure. Gut. 1982 Apr;23(4):265–269. doi: 10.1136/gut.23.4.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ede R. J., Gove C. D., Hughes R. D., Marshall W., Williams R. Reduced brain Na+, K+-ATPase activity in rats with galactosamine-induced hepatic failure: relationship to encephalopathy and cerebral oedema. Clin Sci (Lond) 1987 Mar;72(3):365–371. doi: 10.1042/cs0720365. [DOI] [PubMed] [Google Scholar]
  8. Gazzard B. G., Portmann B., Murray-Lyon I. M., Williams R. Causes of death in fulminant hepatic failure and relationship to quantitative histological assessment of parenchymal damage. Q J Med. 1975 Oct;44(176):615–626. [PubMed] [Google Scholar]
  9. Gazzard B. G., Weston M. J., Murray-Lyon I. M., Flax H., Record C. O., Williams R., Portmann B., Langley P. G., Dunlop E. H., Mellon P. J. Charcoal haemoperfusion in the treatment of fulminant hepatic failure. Lancet. 1974 Jun 29;1(7870):1301–1307. doi: 10.1016/s0140-6736(74)90678-3. [DOI] [PubMed] [Google Scholar]
  10. Gimson A. E., Braude S., Mellon P. J., Canalese J., Williams R. Earlier charcoal haemoperfusion in fulminant hepatic failure. Lancet. 1982 Sep 25;2(8300):681–683. doi: 10.1016/s0140-6736(82)90711-5. [DOI] [PubMed] [Google Scholar]
  11. Gimson A. E., White Y. S., Eddleston A. L., Williams R. Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B. Gut. 1983 Dec;24(12):1194–1198. doi: 10.1136/gut.24.12.1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Gohda E., Tsubouchi H., Nakayama H., Hirono S., Sakiyama O., Takahashi K., Miyazaki H., Hashimoto S., Daikuhara Y. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest. 1988 Feb;81(2):414–419. doi: 10.1172/JCI113334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gove C. D., Hughes R. D., Williams R. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure. Br J Exp Pathol. 1982 Oct;63(5):547–553. [PMC free article] [PubMed] [Google Scholar]
  14. Harrison P. M., Keays R., Bray G. P., Alexander G. J., Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet. 1990 Jun 30;335(8705):1572–1573. doi: 10.1016/0140-6736(90)91388-q. [DOI] [PubMed] [Google Scholar]
  15. Hughes R. D., Lane D. A., Ireland H., Langley P. G., Gimson A. E., Williams R. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease. Clin Sci (Lond) 1985 Jun;68(6):701–707. doi: 10.1042/cs0680701. [DOI] [PubMed] [Google Scholar]
  16. Langley P. G., Hughes R. D., Williams R. Increased factor VIII complex in fulminant hepatic failure. Thromb Haemost. 1985 Oct 30;54(3):693–696. [PubMed] [Google Scholar]
  17. O'Grady J. G., Gimson A. E., O'Brien C. J., Pucknell A., Hughes R. D., Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology. 1988 May;94(5 Pt 1):1186–1192. doi: 10.1016/0016-5085(88)90011-x. [DOI] [PubMed] [Google Scholar]
  18. Rake M. O., Flute P. T., Pannell G., Williams R. Intravascular coagulation in acute hepatic necrosis. Lancet. 1970 Mar 14;1(7646):533–537. doi: 10.1016/s0140-6736(70)90767-1. [DOI] [PubMed] [Google Scholar]
  19. Rolando N., Harvey F., Brahm J., Philpott-Howard J., Alexander G., Gimson A., Casewell M., Fagan E., Williams R. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology. 1990 Jan;11(1):49–53. doi: 10.1002/hep.1840110110. [DOI] [PubMed] [Google Scholar]
  20. Seda H. W., Hughes R. D., Gove C. D., Williams R. Inhibition of rat brain Na+,K+-ATPase activity by serum from patients with fulminant hepatic failure. Hepatology. 1984 Jan-Feb;4(1):74–79. doi: 10.1002/hep.1840040113. [DOI] [PubMed] [Google Scholar]
  21. Vergani D., Mieli-Vergani G., Alberti A., Neuberger J., Eddleston A. L., Davis M., Williams R. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med. 1980 Jul 10;303(2):66–71. doi: 10.1056/NEJM198007103030202. [DOI] [PubMed] [Google Scholar]
  22. Yang S. S., Hughes R. D., Williams R. Digoxin-like immunoreactive substances in severe acute liver disease due to viral hepatitis and paracetamol overdose. Hepatology. 1988 Jan-Feb;8(1):93–97. doi: 10.1002/hep.1840080119. [DOI] [PubMed] [Google Scholar]
  23. Zaki A. E., Ede R. J., Davis M., Williams R. Experimental studies of blood brain barrier permeability in acute hepatic failure. Hepatology. 1984 May-Jun;4(3):359–363. doi: 10.1002/hep.1840040302. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES